About Certara

We accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development.

We optimize biopharmaceutical R&D productivity, commercial value, and patient outcomes through our scalable end-to-end platform integrating biosimulation, regulatory science, and market access solutions.

Our customers include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Since 2014, customers who use Certara’s biosimulation software and technology-enabled services have received over 90% of all new drug and biologic approvals by the FDA.

News Releases